vinko kovacic | Goethe-Universität Frankfurt am Main (original) (raw)
Papers by vinko kovacic
Dialysis Transplantation, 2003
Lenguaje Figurado Y Motivacion Una Perspectiva Desde La Fraseologia 2008 Isbn 978 3 631 57419 5 Pags 191 208, 2008
Polemos Casopis Za Interdisciplinarna Istraživanja Rata I Mira, Jun 26, 2009
rad je izrađen u okviru znanstvenog projekta «javnost, elite, mediji i komunikacijska strategija ... more rad je izrađen u okviru znanstvenog projekta «javnost, elite, mediji i komunikacijska strategija ulaska Hrvatske u eu» na Fakultetu političkih znanosti sveučilišta u Zagrebu. ** dr.sc. božo skoko (bskoko@fpzg.hr) docent je na Fakultetu političkih znanosti sveučilišta u Zagrebu.
Hemodialysis International, 2003
American Journal of Nephrology, 2003
Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and ... more Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and in end-stage renal disease. Metabolic acidosis is associated with many adverse effects: negative nitrogen balance, increased protein decomposition, anorexia, fatigue, bone lesions, impaired function of the cardiovascular system, impaired function of the gastrointestinal system, hormonal disturbances, insulin resistance, hyperkalemia, altered gluconeogenesis and triglyceride metabolism, increased progression of chronic renal failure, and growth retardation in children. Even 'minor' degrees of metabolic acidosis are deleterious. Metabolic acidosis of endstage renal patients could be successfully corrected with bicarbonate hemodialysis and with peroral bicarbonatecontaining phosphate binders, i.e. calcium carbonate. Bicarbonate powder compared with bicarbonate solutions has some advantages and enables a stabile composition of electrolytes. 'High' dialysate bicarbonate (40-42 mmol/l) is a safe, well-tolerated and useful tool for better correction of the metabolic acidosis and must become a standard of hemodialysis treatment. Measured postdialysis blood bicarbonate concentration should be obtained at least every month and correction of metabolic acidosis by maintaining serum bicarbonate 622 mmol/l should be a goal of the management of patients undergoing chronic hemodialysis.
American Journal of Nephrology, 2003
Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and ... more Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and in end-stage renal disease. Metabolic acidosis is associated with many adverse effects: negative nitrogen balance, increased protein decomposition, anorexia, fatigue, bone lesions, impaired function of the cardiovascular system, impaired function of the gastrointestinal system, hormonal disturbances, insulin resistance, hyperkalemia, altered gluconeogenesis and triglyceride metabolism, increased progression of chronic renal failure, and growth retardation in children. Even 'minor' degrees of metabolic acidosis are deleterious. Metabolic acidosis of endstage renal patients could be successfully corrected with bicarbonate hemodialysis and with peroral bicarbonatecontaining phosphate binders, i.e. calcium carbonate. Bicarbonate powder compared with bicarbonate solutions has some advantages and enables a stabile composition of electrolytes. 'High' dialysate bicarbonate (40-42 mmol/l) is a safe, well-tolerated and useful tool for better correction of the metabolic acidosis and must become a standard of hemodialysis treatment. Measured postdialysis blood bicarbonate concentration should be obtained at least every month and correction of metabolic acidosis by maintaining serum bicarbonate 622 mmol/l should be a goal of the management of patients undergoing chronic hemodialysis.
American Journal of Nephrology, 2003
Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and ... more Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and in end-stage renal disease. Metabolic acidosis is associated with many adverse effects: negative nitrogen balance, increased protein decomposition, anorexia, fatigue, bone lesions, impaired function of the cardiovascular system, impaired function of the gastrointestinal system, hormonal disturbances, insulin resistance, hyperkalemia, altered gluconeogenesis and triglyceride metabolism, increased progression of chronic renal failure, and growth retardation in children. Even 'minor' degrees of metabolic acidosis are deleterious. Metabolic acidosis of endstage renal patients could be successfully corrected with bicarbonate hemodialysis and with peroral bicarbonatecontaining phosphate binders, i.e. calcium carbonate. Bicarbonate powder compared with bicarbonate solutions has some advantages and enables a stabile composition of electrolytes. 'High' dialysate bicarbonate (40-42 mmol/l) is a safe, well-tolerated and useful tool for better correction of the metabolic acidosis and must become a standard of hemodialysis treatment. Measured postdialysis blood bicarbonate concentration should be obtained at least every month and correction of metabolic acidosis by maintaining serum bicarbonate 622 mmol/l should be a goal of the management of patients undergoing chronic hemodialysis.
Dialysis Transplantation, 2003
Lenguaje Figurado Y Motivacion Una Perspectiva Desde La Fraseologia 2008 Isbn 978 3 631 57419 5 Pags 191 208, 2008
Polemos Casopis Za Interdisciplinarna Istraživanja Rata I Mira, Jun 26, 2009
rad je izrađen u okviru znanstvenog projekta «javnost, elite, mediji i komunikacijska strategija ... more rad je izrađen u okviru znanstvenog projekta «javnost, elite, mediji i komunikacijska strategija ulaska Hrvatske u eu» na Fakultetu političkih znanosti sveučilišta u Zagrebu. ** dr.sc. božo skoko (bskoko@fpzg.hr) docent je na Fakultetu političkih znanosti sveučilišta u Zagrebu.
Hemodialysis International, 2003
American Journal of Nephrology, 2003
Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and ... more Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and in end-stage renal disease. Metabolic acidosis is associated with many adverse effects: negative nitrogen balance, increased protein decomposition, anorexia, fatigue, bone lesions, impaired function of the cardiovascular system, impaired function of the gastrointestinal system, hormonal disturbances, insulin resistance, hyperkalemia, altered gluconeogenesis and triglyceride metabolism, increased progression of chronic renal failure, and growth retardation in children. Even 'minor' degrees of metabolic acidosis are deleterious. Metabolic acidosis of endstage renal patients could be successfully corrected with bicarbonate hemodialysis and with peroral bicarbonatecontaining phosphate binders, i.e. calcium carbonate. Bicarbonate powder compared with bicarbonate solutions has some advantages and enables a stabile composition of electrolytes. 'High' dialysate bicarbonate (40-42 mmol/l) is a safe, well-tolerated and useful tool for better correction of the metabolic acidosis and must become a standard of hemodialysis treatment. Measured postdialysis blood bicarbonate concentration should be obtained at least every month and correction of metabolic acidosis by maintaining serum bicarbonate 622 mmol/l should be a goal of the management of patients undergoing chronic hemodialysis.
American Journal of Nephrology, 2003
Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and ... more Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and in end-stage renal disease. Metabolic acidosis is associated with many adverse effects: negative nitrogen balance, increased protein decomposition, anorexia, fatigue, bone lesions, impaired function of the cardiovascular system, impaired function of the gastrointestinal system, hormonal disturbances, insulin resistance, hyperkalemia, altered gluconeogenesis and triglyceride metabolism, increased progression of chronic renal failure, and growth retardation in children. Even 'minor' degrees of metabolic acidosis are deleterious. Metabolic acidosis of endstage renal patients could be successfully corrected with bicarbonate hemodialysis and with peroral bicarbonatecontaining phosphate binders, i.e. calcium carbonate. Bicarbonate powder compared with bicarbonate solutions has some advantages and enables a stabile composition of electrolytes. 'High' dialysate bicarbonate (40-42 mmol/l) is a safe, well-tolerated and useful tool for better correction of the metabolic acidosis and must become a standard of hemodialysis treatment. Measured postdialysis blood bicarbonate concentration should be obtained at least every month and correction of metabolic acidosis by maintaining serum bicarbonate 622 mmol/l should be a goal of the management of patients undergoing chronic hemodialysis.
American Journal of Nephrology, 2003
Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and ... more Metabolic acidosis is a condition that is commonly encountered in both chronic renal failure and in end-stage renal disease. Metabolic acidosis is associated with many adverse effects: negative nitrogen balance, increased protein decomposition, anorexia, fatigue, bone lesions, impaired function of the cardiovascular system, impaired function of the gastrointestinal system, hormonal disturbances, insulin resistance, hyperkalemia, altered gluconeogenesis and triglyceride metabolism, increased progression of chronic renal failure, and growth retardation in children. Even 'minor' degrees of metabolic acidosis are deleterious. Metabolic acidosis of endstage renal patients could be successfully corrected with bicarbonate hemodialysis and with peroral bicarbonatecontaining phosphate binders, i.e. calcium carbonate. Bicarbonate powder compared with bicarbonate solutions has some advantages and enables a stabile composition of electrolytes. 'High' dialysate bicarbonate (40-42 mmol/l) is a safe, well-tolerated and useful tool for better correction of the metabolic acidosis and must become a standard of hemodialysis treatment. Measured postdialysis blood bicarbonate concentration should be obtained at least every month and correction of metabolic acidosis by maintaining serum bicarbonate 622 mmol/l should be a goal of the management of patients undergoing chronic hemodialysis.